No Data
No Data
AbbVie To Go Ex-Dividend On January 15th, 2025 With 1.64 USD Dividend Per Share
Market Analysis: AbbVie And Competitors In Biotechnology Industry
Halloween Market Falls, Scared of Meta and Microsoft CapEx | Live Stock
Express News | Abbvie : Raymond James Raises Target Price to $221 From $200
Cantor Fitzgerald Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $240
Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $231
No Data
No Data